Elizabeth O. Hexner

3 ta ish

University of Pennsylvania

1. CRISPR-engineered T cells in patients with refractory cancer

   Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38

   MaqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.102870

2. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

   Stephen Bagley, Zev A. Binder, Lamia Lamrani +32

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.102955

3. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

   Stephen Bagley, Meghan Logun, Joseph A. Fraietta +30

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.102963